{
    "organizations": [],
    "uuid": "0a1a08dd9f3eefda865d4622880a16e8c16fcbd9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-theratechnologies-to-seek-regulato/brief-theratechnologies-to-seek-regulatory-approval-of-trogarzo-in-europe-idUSFWN1S113B",
    "ord_in_thread": 0,
    "title": "BRIEF-Theratechnologies To Seek Regulatory Approval Of Trogarzo In Europe",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Theratechnologies Inc:\n* THERATECHNOLOGIES TO SEEK REGULATORY APPROVAL OF TROGARZOâ„¢ (IBALIZUMAB) IN EUROPE\n* THERATECHNOLOGIES INC - CO WILL PREPARE SUBMISSION FOR REGULATORY APPROVAL FOR TROGARZO IN EUROPE & EXPECT TO FILE AROUND END OF Q3 OF THIS YEAR Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-24T22:59:00.000+03:00",
    "crawled": "2018-04-25T14:48:48.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "theratechnologies",
        "inc",
        "theratechnologies",
        "seek",
        "regulatory",
        "approval",
        "ibalizumab",
        "europe",
        "theratechnologies",
        "inc",
        "co",
        "prepare",
        "submission",
        "regulatory",
        "approval",
        "trogarzo",
        "europe",
        "expect",
        "file",
        "around",
        "end",
        "q3",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}